Victoria Harris
Medical · Smithfield, NCNPI 1871647412
Payments from drug & device makers
Across 114 payments — averaging $12.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$452
- Novo Nordisk$219
- GSK$125
- Amgen$88
- Exact Sciences$63
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$52
- plus $402 from 16 others
What the payments were for
- Food & beverage$1,400100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $452 |
| Novo Nordisk | 12 | $219 |
| GSK | 8 | $125 |
| Amgen | 5 | $88 |
| Exact Sciences | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $52 |
| Astellas Pharma US Inc | 3 | $45 |
| Mylan Specialty L.p. | 3 | $41 |
| Abbott | 2 | $40 |
| Boehringer Ingelheim | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Genentech USA, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic | 1 | $19 |
| Merck | 1 | $19 |
| Antares Pharma, Inc. | 1 | $19 |
| Pfizer | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$1,400 in reported general payments places this provider in the 70th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $15,977 |
| JanuviaSitagliptin Phosphate | 18 | $14,150 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $13,313 |
| JardianceEmpagliflozin | 14 | $12,845 |
| LinzessLinaclotide | 16 | $10,726 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,102 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,740 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,445 |
| Ventolin HfaAlbuterol Sulfate | 21 | $1,407 |
| Atorvastatin Calcium | 94 | $753 |
| Ibuprofen | 40 | $693 |
| Celecoxib | 33 | $549 |
| Gabapentin | 49 | $519 |
| Duloxetine Hcl | 16 | $501 |
| Ondansetron OdtOndansetron | 16 | $461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $125 | $19,05328 claims |
| Novo NordiskOzempic | $219 | $15,97713 claims |
| MerckJanuvia | $19 | $14,15018 claims |
| Boehringer IngelheimJardiance | $34 | $12,84514 claims |
| AbbVieLinzess | $452 | $10,72616 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $25 | $6,10213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 878 medical providers in North Carolina.
Other medical in Smithfield
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.